Federal funding cuts will drive headlines ahead of the midterms, but state credit fundamentals remain strong. Read more here.
Sensei Biotherapeutics shares surged as it acquired Faeth Therapeutics and entered an agreement for a $200 million private placement. The stock rose 177% to $25.32 and is up about 169% for the past 52 ...
Investing.com -- Sensei Biotherapeutics (NASDAQ:SNSE) stock soared 200% Wednesday after the company announced its acquisition of Faeth Therapeutics and a concurrent $200 million private placement.
Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline ...
The company also secured a private placement financing worth around $200 million. ・Sensei Biotherapeutics plans to use the majority of the proceeds to advance PIKTOR. ・Remaining funds will be used for ...
January annual drop is lowest level since March 2025, although still above Bank of England’s 2% target ...
Inflation has fallen to its lowest level in 10 months, official figures show, cementing the case for the Bank of England to ...
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. The only two funds to invest in North America ...